Cidara Therapeutics, Inc. announced the appointment of Nicole Davarpanah, M.D., J.D., as Senior Vice President of Translational Research & Development. In this position, Dr. Davarpanah will lead the company?s oncology efforts, focusing on the strategy for preclinical, translational, and early clinical development activities to identify and advance drug candidates through human proof-of-concept studies. Dr. Davarpanah joins Cidara from Genentech/Roche where she most recently served as Clinical and Translational Lead in Oncology.

During that time, part of her work focused on leading the development strategy of immunotherapy combinations in bladder cancer. Prior to that role, she was the Senior Medical Director of Genitourinary (GU) Immuno-Oncology and Medical Affairs at Genentech/Roche, where she was responsible for the launch of GU oncology products, as well as cultivating strategic partnerships with disease area experts, academic institutions, regulatory agencies and professional societies. Earlier in her career as a medical oncologist, Dr. Davarpanah served as a research fellow focusing on immuno-oncology and GU Cancers at the National Cancer Institute and as a faculty member at Georgetown University, lecturing on the intersection of medicine, law, and technology, and acting as a national speaker and advisor to medical centers and corporations to expand health care access to life saving treatments.

Dr. Davarpanah received her Doctor of Medicine degree from Boston University, as well as her Juris Doctor degree from the University of California, Berkeley.